课题基金 / 基金详情

项目摘要

项目成果

SEBASTIAN JOYCE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of this project is to elucidate the mechanism(s) by which the invariant natural T (iNKT) cells function in health and disease. iNKT cells are important immunoregulatory innate lymphocytes. They mediate the adjuvant function of a-galactosylceramide (otGalCer), a CDId-restricted glycolipid antigen with potent in vivo immunomodulatory activities against metastatic tumours, certain infections and several autoimmune diseases. The rapid and robust cytokine response of in vivo activated iNKT cells mediates their immunoregulatory function. Instructional processes during ontogeny determine the effector properties of lymphocytes. Our approach to understanding iNKT cell biology has been to elucidate the intercellular and intracellular ontogenetic signals that lead to the development and differentiation of functional iNKT cells. We and others have recently discovered that classical nuclear factor KB (NF-kB) signalling is essential for the maturation and function of iNKT cells but not for conventional T cell ontogeny. This function of NF-kB is largely dependent on NFkB1 (cell autonomous), to a lesser extent on NFkB2, and RelB (cell extrinsic) activities. Therefore, a thorough characterisation of signals that activate NF-kB and its consequences during iNKT cell development and differentiation are essential to our understanding of iNKT cell biology. Here, we will test the central hypothesis that NF-KB is a lineage-specific regulator, which processes and integrates diverse extracellular signals that precisely regulate the development and differentiation of functional iNKT cells. To test this central hypothesis, we will pursue the following three integrated yet independent specific aims: (a) define the mechanism(s) that couples TCR signals to NF-kB activation during iNKT cell ontogeny; (6) define the signals that induce apoptosis in iNKT cells during development; and (c) define the mechanism(s) by which NF-kB regulates functional differentiation of iNKT cells. Upon completion of this project, our expectationis to define the molecular mechanism(s) by which NF-kB regulates the ontogeny and differentiation of functional iNKT cells. These findings will significantly enhance our fundamental understanding of iNKT cell biology and will lead to deeper insights into the molecular mechanisms underlying cell fate specification as well as molecular and functional differentiation within the immune system. Additionally, this knowledge can lead to the development of therapeutics that either enhance (adjuvant effect, downregulate autoimmunity) or suppress (cerebral malaria, airway hypersensitivity) iNKT cell function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant
  • 批准号:
    10587388
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2023
  • 负责人:
    SEBASTIAN JOYCE
  • 依托单位:
BLR&D Research Career Scientist Award Application
  • 批准号:
    10454202
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    SEBASTIAN JOYCE
  • 依托单位:
Molecular Basis of CD1D and Natural Killer T Cell Function
BLR&D Research Career Scientist Award Application
  • 批准号:
    9911970
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    SEBASTIAN JOYCE
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究